Cargando…

Essential medicines for cancer: WHO recommendations and national priorities

OBJECTIVE: To examine, for essential anti-cancer medicines, the alignment of national lists of essential medicines and national reimbursable medicines lists with the World Health Organization’s (WHO’s) Model Lists. METHODS: National medicine lists for 135 countries with per-capita gross national inc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Robertson, Jane, Barr, Ronald, Shulman, Lawrence N, Forte, Gilles B, Magrini, Nicola
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	World Health Organization 2016
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5043203/ https://www.ncbi.nlm.nih.gov/pubmed/27843163 http://dx.doi.org/10.2471/BLT.15.163998

Ejemplares similares

Medicines for cancers in children: The WHO model for selection of essential medicines
por: Robertson, Jane, et al.
Publicado: (2015)

Global status of essential medicine selection: a systematic comparison of national essential medicine lists with recommendations by WHO
por: Piggott, Thomas, et al.
Publicado: (2022)

Tough decisions on essential medicines in 2015
por: Magrini, Nicola, et al.
Publicado: (2015)

Selection of WHO-recommended essential medicines for non-communicable diseases on National Essential Medicines Lists
por: Jarvis, Jordan D., et al.
Publicado: (2019)

Essential medicines for mental disorders: comparison of 121 national lists with WHO recommendations
por: Todesco, Beatrice, et al.
Publicado: (2023)

Availability of WHO Essential Medicines for Cancer Treatment in Botswana
por: Martei, Yehoda M., et al.
Publicado: (2018)

Back to the ‘essence’ of medical treatment in oncology: the 2015 WHO Model List of Essential Medicines
por: Eniu, Alexandru, et al.
Publicado: (2016)

The “Square Box”: Therapeutic Equivalence as a Foundation of the WHO Model List of Essential Medicines
por: Cappello, Bernadette, et al.
Publicado: (2020)

Guideline recommendations and antimicrobial resistance: the need for a change
por: Elias, Christelle, et al.
Publicado: (2017)

Priority Medicines for Maternal and Child Health: A Global Survey of National Essential Medicines Lists
por: Hill, Suzanne, et al.
Publicado: (2012)

Shortages and price variability of essential cytotoxic medicines for treating children with cancers
por: Martei, Yehoda M, et al.
Publicado: (2020)

Increasing Access to Surgical Services in Sub-Saharan Africa: Priorities for National and International Agencies Recommended by the Bellagio Essential Surgery Group
por: Luboga, Sam, et al.
Publicado: (2009)

Challenges in updating national guidelines and essential medicines lists in Sub‐Saharan African countries to include WHO‐recommended postpartum hemorrhage medicines
por: Ng'ang'a, Joyce, et al.
Publicado: (2022)

The 19th EML as a global standard: an innovative approach or just an opportunity for new and effective medicines?
por: Magrini, Nicola, et al.
Publicado: (2015)

NOACs Added to WHO’s Essential Medicines List: Recommendations for Future Policy Actions
por: Di Cesare, Mariachiara, et al.
Publicado: (2020)

A comparative analysis of the Libyan national essential medicines list and the WHO model list of essential medicines
por: Mustafa, Asma Abubakr, et al.
Publicado: (2010)

Essential medicines for children: Should we focus on a priority list of medicines for the present?
por: Gitanjali, B
Publicado: (2011)

Priorities for research on family planning impact: recommendations of a WHO Think Tank meeting
por: Ali, Moazzam, et al.
Publicado: (2023)

Competing priorities in treatment decision-making: a US national survey of individuals with depression and clinicians who treat depression
por: Barr, Paul J, et al.
Publicado: (2016)

Patent pooling to increase access to essential medicines
por: Burrone, Esteban, et al.
Publicado: (2019)

Revising the WHO Essential Medicines List for paediatric rheumatology
por: Scott, Christiaan, et al.
Publicado: (2021)

Revising the WHO Essential Medicines List for paediatric rheumatology update
por: Slamang, Waheba, et al.
Publicado: (2022)

Medicines availability for non-communicable diseases: the case for standardized monitoring
por: Robertson, Jane, et al.
Publicado: (2015)

Evaluation of portable devices for medicine quality screening: Lessons learnt, recommendations for implementation, and future priorities
por: Caillet, Céline, et al.
Publicado: (2021)

Erratum to: Medicines availability for non-communicable diseases: the case for standardized monitoring
por: Robertson, Jane, et al.
Publicado: (2015)

WHO essential medicines for reproductive health
por: Gill, Roopan, et al.
Publicado: (2019)

Assessment of availability and challenges of WHO recommended priority life-saving medicines for under five-year children in primary public health facilities of Amhara region
por: Ezezew, Mastewal, et al.
Publicado: (2023)

Comparative Analysis of ADR on China's National Essential Medicines List (2015 Edition) and WHO Model List of Essential Medicines (19th Edition)
por: Zheng, Fangfang, et al.
Publicado: (2018)

Monographs for medicines on WHO’s Model List of Essential Medicines
por: Roth, Lukas, et al.
Publicado: (2018)

Research priorities for non-pharmacological therapies for common musculoskeletal problems: nationally and internationally agreed recommendations
por: Foster, Nadine E, et al.
Publicado: (2009)

National adaptation and implementation of WHO Model List of Essential Medicines: A qualitative evidence synthesis
por: Peacocke, Elizabeth F., et al.
Publicado: (2022)

Medicines and the media: news reports of medicines recommended for government reimbursement in Australia
por: Robertson, Jane, et al.
Publicado: (2013)

Availability and utilization of the WHO recommended priority lifesaving medicines for under five-year old children in public health facilities in Uganda: a cross-sectional survey
por: Nsabagasani, Xavier, et al.
Publicado: (2015)

Pharmacoeconomics and its implication on priority-setting for essential medicines in Tanzania: a systematic review
por: Mori, Amani Thomas, et al.
Publicado: (2012)

Access and use of WHO essential medicines in Italy
por: Petrella, Alessandro, et al.
Publicado: (2023)

Novelty and Priority in Medicine
Publicado: (1887)

Essential Medicines at the National Level: The Global Asthma Network’s Essential Asthma Medicines Survey 2014
por: Bissell, Karen, et al.
Publicado: (2019)

Expanding global access to essential medicines: investment priorities for sustainably strengthening medical product regulatory systems
por: Roth, Lukas, et al.
Publicado: (2018)

Essential tuberculosis medicines and health outcomes in countries with a national essential medicines list
por: Maraj, Darshanand, et al.
Publicado: (2022)

Noncommunicable diseases, access to essential medicines and universal health coverage
por: Beran, David, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_l29nl1oaa5aindgec3unbviaqd